MetaCap

iTonic (ITOC) vs Outset Medical (OM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Outset Medical (OM) has outperformed iTonic (ITOC) over the past year, losing 34.5% versus a loss of 82.0%. Outset Medical is the larger company by market cap ($53.0 million vs $11.6 million), about 4.6 times the size, while iTonic is growing revenue faster (+16.7% vs +5.1%). Outset Medical converts more of its revenue into profit, with a net margin of -68.3% versus -974.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ITOC-81.96%OM-34.50%
+71%-10%-90%
Nov 21, 20251 yearNov 20, 2026
ITOC-97.45%OM-61.69%
+685%+275%-135%
Sep 2, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ITOC versus OM key metrics
MetricITOCOM
Share price$1.59$2.81
Market cap$11.63M$53.03M
1-day change+6.00%-3.44%
YTD return-76.40%-24.26%
1-year return-81.96%-34.50%
5-year return—-99.61%
EPS (TTM)$-4.22$-3.78
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$523.03K$119.48M
Revenue growth (YoY)+16.70%+5.09%
Net income (latest FY)$-5.10M$-81.65M
Gross margin62.59%39.13%
Operating margin-991.71%-55.83%
Net margin-974.68%-68.34%
52-week high$18.40$6.49
52-week low$1.40$2.77
Distance from 52-week high-91.36%-56.70%
Analyst consensus—buy
Avg. price target upside—+172.95%
Average volume42.84K140.40K
Shares outstanding6.84M18.87M
Employees7310
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Outset Medical is about 4.6 times larger than iTonic by market value ($53.03M vs $11.63M).
  • OM has outperformed ITOC by 47.5 percentage points over the past year.
  • Outset Medical is more profitable, keeping -68.3 cents of every revenue dollar as net income versus -974.7 cents for iTonic.
  • iTonic grew revenue faster in its latest fiscal year (+16.70% vs +5.09%).

About iTonic

ITOC stock →

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees

About Outset Medical

OM stock →

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees

ITOC vs OM FAQ

Which is bigger, iTonic or Outset Medical?

Outset Medical (OM) is larger, with a market capitalization of $53.03M compared with $11.63M for iTonic (ITOC).

Which stock has performed better over the past year, ITOC or OM?

OM returned -34.50% over the past 12 months, compared with -81.96% for ITOC (price return, excluding dividends). Past performance does not predict future results.

Are iTonic and Outset Medical in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons